Kerry Wentworth, Chief Regulatory Officer, on April 06, 2026, sold 200,000 shares in Nuvation Bio (NUVB) for $903,560. Following the Form 4 filing with the SEC, Wentworth has control over a total of 53,000 Class A common shares of the company, with 53,000 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1811063/000136945326000005/xslF345X05/form4-04082026_080413.xml
-- Kerry Wentworth, Chief Regulatory Officer, on April 06, 2026, sold 200,000 shares in Nuvation Bio (NUVB) for $903,560. Following the Form 4 filing with the SEC, Wentworth has control over a total of 53,000 Class A common shares of the company, with 53,000 shares held directly.
SEC Filing: